Covestor LTD Atea Pharmaceuticals, Inc. Transaction History
Covestor LTD
- $150 Million
- Q1 2025
A detailed history of Covestor LTD transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Covestor LTD holds 82 shares of AVIR stock, worth $300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82
Previous 67
22.39%
Holding current value
$300
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
48.3MCall Options Held
3.4KPut Options Held
14.5K-
Black Rock Inc. New York, NY9.12MShares$33.5 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$27.9 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.8MShares$17.6 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$17.4 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$9.12 Million2.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $306M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...